Precision medicine is biomarker-guided medicine on systems- levels that takes into account methodological advancements and discoveries of the comprehensive pathophysiological profiles of complex multi-factorial neurodegenerative diseases, such as late-onset sporadic AD. This will allow identifying and characterizing the disease processes… Continue Reading →

This European consortium aims to set up initiatives to prevent Alzheimer’s disease and to better understand the biological mechanisms of this disease. Initially, a register of 24,000 subjects is to be established from which a cohort of 2,000 people with… Continue Reading →